Report Detail
Global Icatibant Acetate API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4638813 |
- 24 October, 2025 |
- Global |
- 102 Pages |
- GIR |
- Chemical & Material
According to our (Global Info Research) latest study, the global Icatibant Acetate API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Icatibant Acetate is the acetate salt form of icatibant, an antagonist of the human bradykinin B2 receptor (B2R), that can be used for the treatment of hereditary angioedema (HAE). Upon administration, icatibant targets and binds to B2R, thereby preventing bradykinin from binding to the B2R. This may prevent bradykinin/B2R-mediated vasodilation, the resulting increase in vascular permeability, and the swelling, inflammation, and pain associated with HAE. This may also prevent or improve pulmonary edema not associated with HAE and improve the associated decrease in blood oxygen levels.
This report is a detailed and comprehensive analysis for global Icatibant Acetate API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Icatibant Acetate API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Icatibant Acetate API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Icatibant Acetate API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Icatibant Acetate API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Icatibant Acetate API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Icatibant Acetate API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., ChemWerth Inc, Bachem AG, Biophore India Pharmaceuticals Pvt. Ltd., Tecoland Corporation, Teva API, Sun Pharmaceutical Industries Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Icatibant Acetate API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Icatibant Acetate Injections
Others
Major players covered
Dr. Reddy’s Laboratories Ltd.
ChemWerth Inc
Bachem AG
Biophore India Pharmaceuticals Pvt. Ltd.
Tecoland Corporation
Teva API
Sun Pharmaceutical Industries Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Icatibant Acetate API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Icatibant Acetate API, with price, sales quantity, revenue, and global market share of Icatibant Acetate API from 2020 to 2025.
Chapter 3, the Icatibant Acetate API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Icatibant Acetate API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Icatibant Acetate API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Icatibant Acetate API.
Chapter 14 and 15, to describe Icatibant Acetate API sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Icatibant Acetate API Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Purity≥98%
- 1.3.3 Purity<98%
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Icatibant Acetate API Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Icatibant Acetate Injections
- 1.4.3 Others
- 1.5 Global Icatibant Acetate API Market Size & Forecast
- 1.5.1 Global Icatibant Acetate API Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Icatibant Acetate API Sales Quantity (2020-2031)
- 1.5.3 Global Icatibant Acetate API Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Dr. Reddy’s Laboratories Ltd.
- 2.1.1 Dr. Reddy’s Laboratories Ltd. Details
- 2.1.2 Dr. Reddy’s Laboratories Ltd. Major Business
- 2.1.3 Dr. Reddy’s Laboratories Ltd. Icatibant Acetate API Product and Services
- 2.1.4 Dr. Reddy’s Laboratories Ltd. Icatibant Acetate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
- 2.2 ChemWerth Inc
- 2.2.1 ChemWerth Inc Details
- 2.2.2 ChemWerth Inc Major Business
- 2.2.3 ChemWerth Inc Icatibant Acetate API Product and Services
- 2.2.4 ChemWerth Inc Icatibant Acetate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 ChemWerth Inc Recent Developments/Updates
- 2.3 Bachem AG
- 2.3.1 Bachem AG Details
- 2.3.2 Bachem AG Major Business
- 2.3.3 Bachem AG Icatibant Acetate API Product and Services
- 2.3.4 Bachem AG Icatibant Acetate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Bachem AG Recent Developments/Updates
- 2.4 Biophore India Pharmaceuticals Pvt. Ltd.
- 2.4.1 Biophore India Pharmaceuticals Pvt. Ltd. Details
- 2.4.2 Biophore India Pharmaceuticals Pvt. Ltd. Major Business
- 2.4.3 Biophore India Pharmaceuticals Pvt. Ltd. Icatibant Acetate API Product and Services
- 2.4.4 Biophore India Pharmaceuticals Pvt. Ltd. Icatibant Acetate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Biophore India Pharmaceuticals Pvt. Ltd. Recent Developments/Updates
- 2.5 Tecoland Corporation
- 2.5.1 Tecoland Corporation Details
- 2.5.2 Tecoland Corporation Major Business
- 2.5.3 Tecoland Corporation Icatibant Acetate API Product and Services
- 2.5.4 Tecoland Corporation Icatibant Acetate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Tecoland Corporation Recent Developments/Updates
- 2.6 Teva API
- 2.6.1 Teva API Details
- 2.6.2 Teva API Major Business
- 2.6.3 Teva API Icatibant Acetate API Product and Services
- 2.6.4 Teva API Icatibant Acetate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Teva API Recent Developments/Updates
- 2.7 Sun Pharmaceutical Industries Ltd.
- 2.7.1 Sun Pharmaceutical Industries Ltd. Details
- 2.7.2 Sun Pharmaceutical Industries Ltd. Major Business
- 2.7.3 Sun Pharmaceutical Industries Ltd. Icatibant Acetate API Product and Services
- 2.7.4 Sun Pharmaceutical Industries Ltd. Icatibant Acetate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
3 Competitive Environment: Icatibant Acetate API by Manufacturer
- 3.1 Global Icatibant Acetate API Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Icatibant Acetate API Revenue by Manufacturer (2020-2025)
- 3.3 Global Icatibant Acetate API Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Icatibant Acetate API by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Icatibant Acetate API Manufacturer Market Share in 2024
- 3.4.3 Top 6 Icatibant Acetate API Manufacturer Market Share in 2024
- 3.5 Icatibant Acetate API Market: Overall Company Footprint Analysis
- 3.5.1 Icatibant Acetate API Market: Region Footprint
- 3.5.2 Icatibant Acetate API Market: Company Product Type Footprint
- 3.5.3 Icatibant Acetate API Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Icatibant Acetate API Market Size by Region
- 4.1.1 Global Icatibant Acetate API Sales Quantity by Region (2020-2031)
- 4.1.2 Global Icatibant Acetate API Consumption Value by Region (2020-2031)
- 4.1.3 Global Icatibant Acetate API Average Price by Region (2020-2031)
- 4.2 North America Icatibant Acetate API Consumption Value (2020-2031)
- 4.3 Europe Icatibant Acetate API Consumption Value (2020-2031)
- 4.4 Asia-Pacific Icatibant Acetate API Consumption Value (2020-2031)
- 4.5 South America Icatibant Acetate API Consumption Value (2020-2031)
- 4.6 Middle East & Africa Icatibant Acetate API Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Icatibant Acetate API Sales Quantity by Type (2020-2031)
- 5.2 Global Icatibant Acetate API Consumption Value by Type (2020-2031)
- 5.3 Global Icatibant Acetate API Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Icatibant Acetate API Sales Quantity by Application (2020-2031)
- 6.2 Global Icatibant Acetate API Consumption Value by Application (2020-2031)
- 6.3 Global Icatibant Acetate API Average Price by Application (2020-2031)
7 North America
- 7.1 North America Icatibant Acetate API Sales Quantity by Type (2020-2031)
- 7.2 North America Icatibant Acetate API Sales Quantity by Application (2020-2031)
- 7.3 North America Icatibant Acetate API Market Size by Country
- 7.3.1 North America Icatibant Acetate API Sales Quantity by Country (2020-2031)
- 7.3.2 North America Icatibant Acetate API Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Icatibant Acetate API Sales Quantity by Type (2020-2031)
- 8.2 Europe Icatibant Acetate API Sales Quantity by Application (2020-2031)
- 8.3 Europe Icatibant Acetate API Market Size by Country
- 8.3.1 Europe Icatibant Acetate API Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Icatibant Acetate API Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Icatibant Acetate API Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Icatibant Acetate API Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Icatibant Acetate API Market Size by Region
- 9.3.1 Asia-Pacific Icatibant Acetate API Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Icatibant Acetate API Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Icatibant Acetate API Sales Quantity by Type (2020-2031)
- 10.2 South America Icatibant Acetate API Sales Quantity by Application (2020-2031)
- 10.3 South America Icatibant Acetate API Market Size by Country
- 10.3.1 South America Icatibant Acetate API Sales Quantity by Country (2020-2031)
- 10.3.2 South America Icatibant Acetate API Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Icatibant Acetate API Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Icatibant Acetate API Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Icatibant Acetate API Market Size by Country
- 11.3.1 Middle East & Africa Icatibant Acetate API Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Icatibant Acetate API Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Icatibant Acetate API Market Drivers
- 12.2 Icatibant Acetate API Market Restraints
- 12.3 Icatibant Acetate API Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Icatibant Acetate API and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Icatibant Acetate API
- 13.3 Icatibant Acetate API Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Icatibant Acetate API Typical Distributors
- 14.3 Icatibant Acetate API Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Icatibant Acetate API. Industry analysis & Market Report on Icatibant Acetate API is a syndicated market report, published as Global Icatibant Acetate API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Icatibant Acetate API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
